Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 36 Records) |
| Query Trace: Leukocytosis and JAK2[original query] |
|---|
| A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia 2010 Sep 24 (9): 1574-9. Passamonti F, Rumi E, Pietra D, Elena C, Boveri E, Arcaini L, Roncoroni E, Astori C, Merli M, Boggi S, Pascutto C, Lazzarino M, Cazzola |
| [JAK2 V617F and exon 12 genetic variations in Korean patients with BCR/ABL1-negative myeloproliferative neoplasms]. The Korean journal of laboratory medicine 2010 Dec 30 (6): 567-74. Kim Jeong Tae, Cho Yong Gon, Choi Sam Im, Lee Young Jin, Kim Hye Ran, Jang Sook Jin, Moon Dae Soo, Park Young Jin, Park Ge |
| Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study. Annals of hematology 2011 Aug 90 (8): 933-8. Palandri Francesca, Polverelli Nicola, Catani Lucia, Ottaviani Emanuela, Baccarani Michele, Vianelli Nico |
| Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Clinical lymphoma, myeloma & leukemia 2011 Jun 11 Suppl 1 S25-7. Passamonti Frances |
| Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood 2011 Mar 117 (10): 2813-6. Passamonti Francesco, Elena Chiara, Schnittger Susanne, Skoda Radek C, Green Anthony R, Girodon François, Kiladjian Jean-Jacques, McMullin Mary Frances, Ruggeri Marco, Besses Carles, Vannucchi Alessandro M, Lippert Eric, Gisslinger Heinz, Rumi Elisa, Lehmann Thomas, Ortmann Christina A, Pietra Daniela, Pascutto Cristiana, Haferlach Torsten, Cazzola Mar |
| Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 1 29 (7): 789-96. Pardanani Animesh, Gotlib Jason R, Jamieson Catriona, Cortes Jorge E, Talpaz Moshe, Stone Richard M, Silverman Michael H, Gilliland D Gary, Shorr Jolene, Tefferi Ayal |
| [Clinical significance of the quantification of JAK2V617F allele burden in classical Ph-negative myeloproliferative neoplasms]. Medicina clínica 2012 Oct 139 (9): 373-8. Kerguelén Fuentes Ana Esther, Hernández-Maraver Dolores, Lombardia Luis, Canales Albendea Miguel Angel, Rodriguez de la Rúa A |
| [Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients]. Medicina clínica 2015 Mar 144 (6): 247-53. Angona Anna, Alvarez-Larrán Alberto, Bellosillo Beatriz, Martínez-Avilés Luz, Garcia-Pallarols Francesc, Longarón Raquel, Ancochea Àgueda, Besses Carl |
| Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. Blood 2014 Aug 124 (7): 1062-9. Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario, |
| [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2014 12 35 (12): 1069-73. Cui Yajuan, Li Bing, Jiang Qian, Xu Zefeng, Qin Tiejun, Zhang Peihong, Zhang Yue, Xiao Zhiji |
| Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms. Oncology letters 2015 Feb 9 (2): 735-738. Zhang Shu-Peng, Li Hui, Lai Ren-She |
| Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms. Leukemia research 2016 Apr 46 18-25. Gugliotta Luigi, Iurlo Alessandra, Gugliotta Gabriele, Tieghi Alessia, Specchia Giorgina, Gaidano Gianluca, Scalzulli Potito R, Rumi Elisa, Dragani Alfredo, Martinelli Vincenzo, Santoro Cristina, Randi Maria Luigia, Tagariello Giuseppe, Candoni Anna, Cattaneo Daniele, Ricco Alessandra, Palmieri Raffaele, Liberati Marina A, Langella Maria, Rago Angela, Bergamaschi Micaela, Monari Paola, Miglio Rossella, Santoro Umberto, Cacciola Rossella, Rupoli Serena, Mastrullo Lucia, Musto Pellegrino, Mazzucconi Maria Gabriella, Vignetti Marco, Cortelezzi Agostino, Vianelli Nicola, Martino Bruno, Stefano Valerio De, Passamonti Francesco, Vannucchi Alessandro M, |
| Polycythemia vera: from new, modified diagnostic criteria to new therapeutic approaches. Clinical advances in hematology & oncology : H&O 2017 9 15 (9): 700-707. Maffioli Margherita, Mora Barbara, Passamonti Frances |
| Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 0 26 (1): 115-121. Prajs Iwona, Kuliczkowski Kazimie |
| The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia. American journal of hematology 2017 Feb . Mudireddy Mythri, Barraco Daniela, Hanson Curtis A, Pardanani Animesh, Gangat Naseema, Tefferi Ayal |
| Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms. Annals of hematology 2018 Jan 97 (1): 109-121. Boddu Prajwal, Masarova Lucia, Verstovsek Srdan, Strati Paolo, Kantarjian Hagop, Cortes Jorge, Estrov Zeev, Pierce Sherry, Pemmaraju Nave |
| Prevalence of MPL (W515K/L) Mutations in Patients with Negative-JAK2 (V617F) Myeloproliferative Neoplasm in North-East of Iran. Iranian journal of pathology 2018 13 (4): 397-402. Shams Seyyede Fatemeh, Ayatollahi Hossein, Sadeghian Mohammad Hadi, Afzalaghaee Monavar, Shakeri Sepideh, Yazdandoust Ehsan, Sheikhi Maryam, Amini Nafiseh, Bakhshi Samane, Bahrami Afsa |
| Polycythemia Vera Presenting With Normal Hemoglobin and Hematocrit: A Rare Variant. Cureus 2020 7 12 (6): e8404. Erdinc Burak, Ramachandran Preethi, Boris Avezbakiy |
| Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis. Blood advances 2020 12 4 (24): 6353-6363. Wouters Hanneke J C M, Mulder René, van Zeventer Isabelle A, Schuringa Jan Jacob, van der Klauw Melanie M, van der Harst Pim, Diepstra Arjan, Mulder André B, Huls Gerw |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report. Leukemia research reports 2021 5 15 100243. Morsia E, Goteri G, Torre E, Garvey K B, Discepoli G, Tassoni A, Mancini S, Giantomassi F, Poloni A, Olivieri A, Rupoli |
| CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Annals of hematology 2021 Apr . Qian Yi, Chen Yan, Li Xiaomi |
| High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms. Clinical laboratory 2021 11 67 (11): . Chatambudza Moses, Skhosana Lindiwe, Ketseoglou Irene, Wiggill Trac |
| MPN-354 Characteristics of Patients With Myelofibrosis Taking Ruxolitinib for 3 or More Years. Clinical lymphoma, myeloma & leukemia 2022 9 22 Suppl 2 S334. Masarova Lucia, Bose Prithviraj, Pemmaraju Naveen, Kantarjian Hagop, Estrov Zeev, Verstovsek Srd |
| Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study. International journal of hematology 2022 7 116 (5): 696-711. Edahiro Yoko, Ito Tomoki, Gotoh Akihiko, Nakamae Mika, Kimura Fumihiko, Koike Michiaki, Kirito Keita, Wada Hideho, Usuki Kensuke, Tanaka Takayuki, Mori Takehiko, Wakita Satoshi, Saito Toshiki I, Kada Akiko, Saito Akiko M, Shimoda Kazuya, Sugimoto Yuka, Kurokawa Toshiro, Tomita Akihiro, Hashimoto Yoshinori, Akashi Koichi, Matsumura Itaru, Takenaka Katsuto, Komatsu Nor |
| Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases. Blood cancer journal 2022 3 12 (3): 44. Gangat Naseema, Jadoon Yamna, Szuber Natasha, Hanson Curtis A, Wolanskyj-Spinner Alexandra P, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
| Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report. Cureus 2022 3 14 (2): e22422. Pelkey Lauren J, Graham David M, Zakem Michael H, Muza-Moons Michelle |
| Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia. Cancer genetics 2023 7 276-277 43-47. Lisa M Marinelli, Joshua T Romain, William Ehman, Veronica Ortega, Gopalrao Velagaleti, Thomas F Gibbons, Ashley Nazario-Toole, Allen R Holm |
| One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 2024 1 14 (1): 11. Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Teffe |
| One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 2024 1 14 (1): 10. Giuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M Vannucchi, Paola Guglielmel |
- Page last reviewed:Feb 1, 2024
- Content source: